Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Overview
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Companies Involved in Therapeutics Development
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drug Profiles
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Discontinued Products
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Product Development Milestones
Featured News & Press Releases
Oct 19, 2022: Enzychem Lifesciences announces poster presentation of EC-18 at the Radiation Research Society 2022 annual meeting
Oct 19, 2022: Enzychem Lifesciences announces poster presentation of EC-18 at the Radiation Research Society 2022 annual meeting
Jul 21, 2022: Eckert & Ziegler Affiliate receives further NIAID funding for clinical development
Apr 26, 2022: New studies published comparing BIO 300 to Neulasta for acute radiation syndrome
Mar 24, 2022: Tanner Pharma increases Europe-based inventory of Leukine to expand availability and enhance response to potential radiation exposure due to the ongoing Conflict in Ukraine
Dec 01, 2021: Statera Biopharma announces FDA lifts clinical hold on entolimod
Nov 18, 2021: Enveric Biosciences announces positive preclinical data for EV102 Radiodermatitis Drug Candidate
Sep 22, 2021: Humanetics announces results from phase 1 trial of BIO 300 oral powder
Jul 20, 2021: Neuropathix announces publication of PCT patent application for the treatment of radiation dermatitis and other skin disorders
Jun 08, 2021: Affiliate receives additiol NIAID funding to advance pharmaceutical development
Feb 18, 2021: Partner Therapeutics announces publication of two studies demonstrating Leukine improves survival in Acute Radiation Syndrome (ARS)
Feb 08, 2021: Enzychem Lifesciences announces poster presentation at AACR Virtual Annual Meeting 2021
Jan 26, 2021: Enzychem Lifesciences receives SA grant funding to evaluate EC-18 as a protective agent for radiation and pathogen-induced tissue damage and inflammation in space
Oct 20, 2020: Humanetics presents at the Annual Radiation Research Society meeting
Oct 15, 2020: Meabco’s drug candidate efficiently mitigates radiation-induced gastrointestil syndrome in mice
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, 2022
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Discontinued Products, 2022